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ABSTRACT
With the continued accumulation of genomic data at ever increasing resolution, the challenge 
ahead lies in reading out meaningful clinical/biological information from the data that can 
contribute to a better understanding of the cancerous process. The need for novel approaches 
and new statistical methods is therefore strong. 
The present thesis aims to contribute to the field with three problem-specific applications that 
hopefully will aid researchers in a better understanding of genomic data. 
The first paper exemplifies the adaptation of a piecewise-linear regression framework for 
integrative analysis of DNA copy number aberrations and gene expression (mRNA) data. The 
method helps to identify the association between copy number and gene expression, but it 
takes a further step and allows detection of changing patterns and changepoints that could 
serve as a proxy for the degree of genomic instability that causes disruptions in feedback-
mechanisms. 
The second paper advocates the adaptation of a mediation analysis for a concomitant analysis 
of DNA copy number aberrations, mRNA and survival data. The paper offers ways of 
statistical inference by means of the Delta method applicable concomitantly on a large 
number of genes. If a mediation effect is observed for a specific gene, we hypothesize that the 
specific gene is a driver gene. If no mediation effect is observed, possible associations 
between DNA copy number aberrations and the outcome are likely to indicate passenger 
genes.   
The third paper is a more applied/clinical work using applied statistics which identified a 
novel panel of 12-genes that can serve as a prognostic tool for breast cancer specific survival.  
The thesis concludes with a methodological description in which we describe an easy 
permutation-based approach for testing the clonal origins of multiple tumors. The main 
assumption of the proposed method is that if two tumors that share a common origin, or if the 
alleged secondary tumor is clonally related to the primary tumor, they share a higher and 
tumor-specific amount of matching chromosomal aberrations (gains or deletions) than 
recurrent chromosomal aberrations can explain.
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